Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

Clinical trial NCT06952660 · RECRUITING

Trial details

NCT number: NCT06952660
Sponsor: Pfizer
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Cervical Cancer

Start date: 2025-05-07
Primary completion: 2028-12-13
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.